Showing results (811-820 of 1,184) with videos related to
Sort By:
Pageof 119
Cancer Cytopathology|June 20, 2014
Cytologic features of parathyroid fine-needle aspiration on ThinPrep preparationsShelley I Odronic, Jordan P Reynolds, Deborah J ChuteCancer Cytopathology|July 30, 2020
Diagnostic performances of the Afirma Gene Sequencing Classifier in comparison with the Gene Expression Classifier: A meta-analysisHuy Gia Vuong, Truong Phan Xuan Nguyen, Lewis A Hassell, et al.Cancer Cytopathology|July 11, 2020
Should uncertainty concerning the risk of malignancy be included in diagnostic (nongynecologic) cytopathology reports?David N Poller, Fernando SchmittCancer Cytopathology|January 18, 2014
Hürthle cells in fine-needle aspirates of the thyroid: a review of their diagnostic criteria and significanceManon AugerCancer Cytopathology|July 20, 2012
Interrater agreement of anal cytologyTeresa M Darragh, Diane Tokugawa, Philip E Castle, et al.Cancer Cytopathology|November 8, 2012
The addition of RPMI significantly improves the cellularity of cerebrospinal fluid cytology specimens over timeScott A Renshaw, Suresh Gupta, Michael Campos, et al.Cancer Cytopathology|January 15, 2014
Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytologyVickie Y Jo, Edmund S Cibas, Geraldine S PinkusCancer Cytopathology|August 17, 2022
Utility of p16/Ki67 double immunocytochemistry for detection of cervical adenocarcinomaAyumi Ryu, Keiichiro Honma, Azusa Shingetsu, et al.Cancer Cytopathology|September 3, 2021
A multi-institutional study of salivary gland cytopathology: Application of the Milan System for Reporting Salivary Gland Cytopathology in JapanKayoko Higuchi, Makoto Urano, Jun Akiba, et al.Cancer Cytopathology|September 3, 2021
Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytologyIlaria Girolami, Ersilia Lucenteforte, Albino Eccher, et al.Pageof 119